US National Institutes of Health: Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional)

This opportunity uses the R21 Exploratory/Developmental Research Grants funding mechanism.

Funding Opportunity Announcement (FOA) Number: PA-18-280

This award encourages implementation research projects designed in partnership with global and domestic service providers, to target the particular needs in the selected community, to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment (ART), and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression.

Companion Schemes

  • PA-18-279 – Research Project Grant (R01)

Funding & Duration

The combined budget for direct costs for the two-year project may not exceed USD $275,000 (approx. AUD $371,000). No more than USD $200,000 (approx. AUD $270,000) may be requested in any single year.

The maximum project period is 2 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Arts, Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Professions, Sciences and tagged . Bookmark the permalink.

Comments are closed.